3 hours Aprea Therapeutics, Inc. (NASDAQ:APRE) Director Buys $131,700.00 in StockMarketBeat
Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Free Report) Director Marc Duey bought 30,000 shares of the stock in a transaction on Wednesday, October 16th. The shares were bought at an average price of $4.39 per share, with a total value of $131,700.00….
X